Pejin D, Popović S, Dokić M, Felle D, Stefanović N
Acta Chir Iugosl. 1990;37 Suppl 1:11-5.
The paper deals with the results of clinical preparations for the application of allogenic bone marrow transplantation at the Clinic of Hematology in Novi Sad. The obligation of the definite treatment of patients below 45 years by allogenic and autologous bone marrow transplantation results from the acceptance of the Yugoslav protocols for acute leukaemia treatment. Thus immunogenotypical analyses, so far performed in patients with severe aplastic anaemia have been extended to patients with acute leukaemia as well and then to patients with chronic myelogenous leukaemia, high risk lymphocYtic lymphoma and myeloma multiplex with resistance to standard chemotherapy and their potential sibling donors. The bone marrow transplantation Unit has been set up, the team of specialists has been formed and educated and the protocol for allogenic transplantation with Busulfan and cyclophosphamide combination for pretransplant conditioning has been adopted. In research work concerning the field of bone marrow transplantation a particular emphasis has been put on the working out of a mathematical model for optimal timing of bone marrow transplantation in patients with acute myelogenous leukaemia.
本文论述了诺维萨德血液学诊所进行同种异体骨髓移植临床准备工作的结果。按照南斯拉夫急性白血病治疗方案,有义务对45岁以下患者采用同种异体和自体骨髓移植进行明确治疗。因此,迄今为止在严重再生障碍性贫血患者中进行的免疫基因型分析已扩展至急性白血病患者,进而扩展至慢性粒细胞白血病、对标准化疗耐药的高危淋巴细胞淋巴瘤和多发性骨髓瘤患者及其潜在的同胞供体。已设立骨髓移植科,组建并培训了专家团队,采用了白消安和环磷酰胺联合进行移植前预处理的同种异体移植方案。在骨髓移植领域的研究工作中,特别着重于建立一个数学模型,以确定急性髓细胞白血病患者骨髓移植的最佳时机。